We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.
- Authors
Silverman, Lewis R; Demakos, Erin P; Peterson, Bercedis L; Kornblith, Alice B; Holland, Jimmie C; Odchimar-Reissig, Rosalie; Stone, Richard M; Nelson, Douglas; Powell, Bayard L; DeCastro, Carlos M; Ellerton, John; Larson, Richard A; Schiffer, Charles A; Holland, James F
- Abstract
Patients with high-risk myelodysplastic syndrome (MDS) have high mortality from bone marrow failure or transformation to acute leukemia. Supportive care is standard therapy. We previously reported that azacitidine (Aza C) was active in patients with high-risk MDS.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Vol 20, Issue 10, p2429
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2002.04.117